|WPC Scientific Update 2015|
Learning Objectives: To discuss new innovations in therapy from three angles, including pharmacological, reparative strategies such as DBS, and mechanical bio-engineering; To understand the potential roles and limitations of existing and emerging non-pharmacological approaches to the management of Parkinson's as well as other potential applications.
SESSION II- Alpha-nuclein why is it so important to Parkinson's?
Learning Objectives: To understand the importance of the mechanisms responsible for the maintenance of the well being of proteins.
Presented on October 7, 2015
SESSION III- Emerging Targets in Parkinson's
Learning Objectives: To understand current unmet needs and appreciate the obstacles that must be overcome in order to develop a neuroprotective therapy; To understand how to identify targets to alleviate the symptoms unresponsive to dopaminergic treatment or the side effects of dopaminergic treatments.
SESSION IV- Exercise: What do we know about how it impacts Parkinson's?
Learning Objectives: To explain how exercise impacts a Parkinson patient's health and well being from three perspectives, including neurophysiological impact, clinical impact, and rehabilitation impact.
Presented on October 8, 2015
SESSION V- Cognitive Challenges and Parkinson's: What can really be done?
Learning Objectives: To describe the clinical features, syndromes and proposed mechanisms of cognitive dysfunction across the spectrum of Parkinson's disease; To describe the available and emerging treatments for cognitive impairment associated with Parkinson's.
SESSION VI- Gene & Stem Cell Therapy: Can these really impact Parkinson's?
Learning Objectives: To appreciate the experimental development and current applications of cell and gene based therapies.